EN DE
STOCK COMPARISON

Shenzhen YHLO Biotech Co. Ltd. A vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Shenzhen YHLO Biotech Co. Ltd. A (688575) and Abbott Laboratories (ABT) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Shenzhen YHLO Biotech Co. Ltd. A trades at ¥9.44 versus a fair value of ¥0.92 (-90%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).
Shenzhen YHLO Biotech Co. Ltd. A
688575.SHG · CNY · Health Care
-90%
upside to fair value
overvalued
Price¥9.44
Fair Value¥0.92
Quality46/100
Abbott Laboratories
ABT · USD · Health Care
-31%
upside to fair value
overvalued
Price$108
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Shenzhen YHLO Biotech Co. Ltd. AAbbott Laboratories
Valuation
189.8×P/E (TTM)27.7×
3.03×P/S (TTM)3.89×
2.01×P/B3.36×
11.8×EV/EBITDA15.1×
—PEG1.47×
0.2%Dividend yield—
¥0.02Dividend per share—
Profitability
2%Net margin14%
11%Operating margin13%
3%Return on equity12%
3%Return on assets6%
Growth
-5%Revenue growth (YoY)8%
-23.1%Avg. growth/yr (3Y)0.5%
12.6%Avg. growth/yr (5Y)5.1%
Balance & size
0.22×Debt / equity0.19×
$805MMarket cap$175B
expensiveGrowth qualityhealthy

Abbott Laboratories leads: 4 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Shenzhen YHLO Biotech Co. Ltd. Aof which business quality 48 · market factors 26 Abbott Laboratoriesof which business quality 66 · market factors 51
ProfitabilityMargins and returns on capital today
31
50
Quality GrowthAre margins and returns improving?
27
47
CashflowEarnings quality: real cash, not paper profit
52
71
Fin. StrengthBalance sheet, leverage, solvency risk
72
80
InvestmentDisciplined investing over empire-building
60
65
Low VolatilityCalm price path (market factor)
84
83
MomentumPrice trend over the last 3–12 months (market factor)
2
40
52W MomentumDistance to the 52-week high (market factor)
2
33
Net IssuanceBuybacks instead of dilution
45
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Shenzhen YHLO Biotech Co. Ltd. A

DCF Models¥2.26
Earnings-Based¥0.59
Dividend Discount¥4.05
Multiples¥1.56
Asset-Based¥3.16
Growth DCF¥2.20
Economic Profit¥1.84
Growth Earnings¥0.80

24 of 25 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Shenzhen YHLO Biotech Co. Ltd. A
Bear ¥0.69Fair Value ¥0.92Bull ¥1.16
¥9.44 = current price (white tick)
Abbott Laboratories
Bear $51.84Fair Value $74.79Bull $94.43
$108 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Shenzhen YHLO Biotech Co. Ltd. A · Health Care

Quality score46 · below median
Fair value upside-90% · bottom 25%

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-31% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Shenzhen YHLO Biotech Co. Ltd. A trades at ¥9.44 versus a fair value of ¥0.92 (-90%), while Abbott Laboratories trades at $108 versus $74.79 (-31%).

Abbott Laboratories has the higher quality score (67/100).

See the full analysis →
Shenzhen YHLO Biotech Co. Ltd. A · Abbott Laboratories

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Shenzhen YHLO Biotech Co. Ltd. A

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Abbott Laboratories

UnitedHealth Group vs Abbott LaboratoriesUnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs Amgen
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.